(Q80581138)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17617250%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

No patient left behind--better treatments for resistant HIV infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17617250%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Bernard Hirschel

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17617250%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Thomas Perneger

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17617250%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

language of work or name

English

0 references

publication date

1 July 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17617250%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17617250%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

370

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17617250%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

9581

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17617250%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

3-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17617250%20AND%20SRC:MED&resulttype=core&format=json

Discovery and selection of TMC114, a next generation HIV-1 protease inhibitor

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961022-8

7 January 2021

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961022-8

7 January 2021

Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961022-8

7 January 2021

The tablet formulation of lopinavir/ritonavir provides similar bioavailability to the soft-gelatin capsule formulation with less pharmacokinetic variability and diminished food effect.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961022-8

7 January 2021

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961022-8

7 January 2021

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961022-8

7 January 2021

TMC125 displays a high genetic barrier to the development of resistance: evidence from in vitro selection experiments

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961022-8

7 January 2021

Efficacy and safety of etravirine (TMC125) in patients with highly resistant HIV-1: primary 24-week analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961022-8

7 January 2021

Pharmacokinetics and antiretroviral response to darunavir/ritonavir and etravirine combination in patients with high-level viral resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961022-8

7 January 2021

10.1016/S0140-6736(07)61022-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17617250%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference